[go: up one dir, main page]

AU2002214441A1 - 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain - Google Patents

1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain

Info

Publication number
AU2002214441A1
AU2002214441A1 AU2002214441A AU1444102A AU2002214441A1 AU 2002214441 A1 AU2002214441 A1 AU 2002214441A1 AU 2002214441 A AU2002214441 A AU 2002214441A AU 1444102 A AU1444102 A AU 1444102A AU 2002214441 A1 AU2002214441 A1 AU 2002214441A1
Authority
AU
Australia
Prior art keywords
tetrahydropyridazino
diones
quinoline
pain
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002214441A
Inventor
Vernon Alford
Thomas Bare
Christine Barlaam
Dean Gordon Brown
Carey Lynn Horchler
Frances Marie Mclaren
Megan Murphy
Gary Banks Steelman
Rebecca Ann Urbanek
Edward Vacek
Wenhua Xiao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2002214441A1 publication Critical patent/AU2002214441A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2002214441A 2000-09-29 2001-09-28 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain Abandoned AU2002214441A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23675400P 2000-09-29 2000-09-29
US60236754 2000-09-29
PCT/SE2001/002124 WO2002026739A1 (en) 2000-09-29 2001-09-28 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain

Publications (1)

Publication Number Publication Date
AU2002214441A1 true AU2002214441A1 (en) 2002-04-08

Family

ID=22890811

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002214441A Abandoned AU2002214441A1 (en) 2000-09-29 2001-09-28 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain

Country Status (5)

Country Link
US (1) US20050070544A1 (en)
EP (1) EP1325005A1 (en)
JP (1) JP2004509963A (en)
AU (1) AU2002214441A1 (en)
WO (1) WO2002026739A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420590D0 (en) * 1993-10-22 1994-11-30 Zeneca Ltd Pyridazino quinoline compounds
GB9507318D0 (en) * 1995-04-07 1995-05-31 Zeneca Ltd Alpha substituted pyridazino quinoline compounds
EP1244660B1 (en) * 1999-12-23 2006-03-22 AstraZeneca AB Methods and compositions for the treatment of pain
EP1244453A1 (en) * 1999-12-23 2002-10-02 AstraZeneca AB Method and composition for the treatment of pain
ATE274513T1 (en) * 1999-12-23 2004-09-15 Astrazeneca Ab COMPOUNDS AND METHODS FOR TREATING PAIN
HUP0300043A3 (en) * 1999-12-23 2007-05-02 Astrazeneca Ab Method and composition for the treatment of pain
EP1244664A1 (en) * 1999-12-23 2002-10-02 AstraZeneca AB Compounds and methods for the treatment of pain

Also Published As

Publication number Publication date
EP1325005A1 (en) 2003-07-09
US20050070544A1 (en) 2005-03-31
WO2002026739A1 (en) 2002-04-04
JP2004509963A (en) 2004-04-02

Similar Documents

Publication Publication Date Title
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
IL187512A0 (en) Use of (s,s)-reboxetine in the treatment of pain conditions and incontinence
AU2001264313A1 (en) Pyrazolopyridine compounds and use thereof as drugs
AU5788300A (en) Medical treatment method and kit
GB0109414D0 (en) Well treatment fluids and methods for the use thereof
EP1392292A4 (en) Pyranoindazoles and their use for the treatment of glaucoma
AU2001257069A1 (en) Photostimulaton treatment apparatus and methods for use
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2002219229A1 (en) Means for the diagnosis and therapy of CTCL
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2002354476A1 (en) Pyrazolopyridine derivatives and medicinal use thereof
AU2001235595A1 (en) 4-heteroaryl-1,4-diazabicyclo(3.2.2)nonane, preparation and therapeutic use thereof
AU2001264042A1 (en) 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
AU2001264044A1 (en) 1,4-diazabicyclo(3.2.2)nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof
PL349364A1 (en) Use of pyridazino[4,5-b
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2001259507A1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
AU2001270129A1 (en) Human phosphodiesterases
AU4204700A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU2001296173A1 (en) 3,8-diazabicyclo(3.2.1)octanes and their use in the treatment of cardiac arrhythmias
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU2001292500A1 (en) 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
AU2566201A (en) Compounds and methods for the treatment of pain
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas